GlassScriptPhysician profile
Jessie L Powell
NPI 1407321482
$1,543.21
in general payments reported to CMS, 2019-2025
9 companies · $537 in 2025
The $537 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $115 · 2023: $348 · 2024: $419 · 2025: $537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,303.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $675.10 | 2021-2025 | Collagenase Santyl, Iodosorb Ointment 40g USA, Acticoat 4" X 4" |
| Avita Medical Americas, LLC | $208.88 | 2024-2025 | Cohealyx, Recell, Permeaderm |
| Ethicon US, LLC | $207.29 | 2023-2025 | Surgicel Nu-Knit, Stratafix, Dermabond |
| Integra Lifesciences Corporation | $158.03 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kci USA, INC. | $95.01 | 2021-2022 | |
| Kerecis Limited | $70.00 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Convatec INC. | $59.15 | 2021-2024 | |
| Solventum Corporation | $50.38 | 2024 | V.A.C. Veraflo, Promogran Prisma, Activ.A.C. |
| Urgo Medical North America, LLC | $19.37 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessie Powell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.